Author correction to “An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis” [Acta Pharm Sin B 11 (2021) 835–847]
Acta Pharmaceutica Sinica B · 2026-10
DOI: 10.1016/j.apsb.2026.10.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-10. Verfasst von Xianyan Qin und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Qin, X., Xu, Y., Zhou, X., Gong, T., Zhang, Z., & Fu, Y. (2026). Author correction to “An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis” [Acta Pharm Sin B 11 (2021) 835–847]. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.10.011
Vancouver
Qin X, Xu Y, Zhou X, Gong T, Zhang Z, Fu Y. Author correction to “An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis” [Acta Pharm Sin B 11 (2021) 835–847]. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.10.011
BibTeX
@article{Qin2026,
author = {Qin, Xianyan and Xu, Yingying and Zhou, Xu and Gong, Tao and Zhang, Zhi-Rong and Fu, Yao},
title = {Author correction to “An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis” [Acta Pharm Sin B 11 (2021) 835–847]},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.10.011}
}
EUVIMED